Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-19 Purchase | 2021-11-23 4:12 pm | Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer | 100 | $6.695 | $670 | 100 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-08 Option Award | 2024-02-12 4:05 pm | N/A 2034-02-07 | Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer | 175,000 | $0 | 175,000 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-06 08:07 am | N/A 2033-01-31 | Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 7:17 pm | N/A N/A | Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer | 55,000 | $0 | 55,000 (Direct) | View |
| 2021-12-28 Ownership | 2022-02-10 4:08 pm | N/A N/A | Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer | 45 | $0 | 100 (Direct) | View |
Ownership | 2022-02-10 4:08 pm | N/A N/A | Astria Therapeutics Inc. | ATXS | Komjathy Andrew Chief Commercial Officer | 0 | $0 | 100 (Indirect) | View |
| 2021-06-02 Option Award | 2021-06-02 7:19 pm | N/A 2031-03-31 | CATABASIS PHARMACEUTICALS INC | CATB | Komjathy Andrew Chief Commercial Officer | 600,000 | $0 | 600,000 (Direct) | View |
| 2020-02-12 Option Award | 2020-02-14 12:57 pm | N/A 2030-02-11 | CATABASIS PHARMACEUTICALS INC | CATB | Komjathy Andrew Chief Commercial Officer | 35,000 | $0 | 35,000 (Direct) | View |